Table 6 The length of LZD and outcomes for RR/MDR-TBM patients
Group | Case | Age range (y) | Length of disease(d) | BMRC | HIV | Mi-TB | Regimen | Length of lzd(m) | Outcomes |
|---|---|---|---|---|---|---|---|---|---|
LZD | Case1 | 15–24 | 3 | III | − | + | LZD-INH-PZA-Mfx-Cs | 3 | Survival |
Case2 | 25–34 | 7 | II | − | − | LZD-Mfx-CS-PZA-INH-Pto | 6 | Survival | |
Case3 | 25–34 | 14 | III | − | − | LZD-Mfx-Pto-PZA-Am | 6 | Survival | |
Case4 | 25–34 | 1 | II | − | + | LZD-INH-PAZ-EMB-Lfx-Am | 6 | Survival | |
Case5 | 25–34 | 3 | I | + | + | LZD-Mfx-Pto-PZA-Am | 8 | Survival | |
Case6 | 15–24 | 1 | I | + | + | LZD-Mfx-PZA-Pto-Am | 9 | Survival | |
Case7 | 35–44 | 15 | I | − | − | LZD-INH-PZA-Mfx-CS | 10 | Survival | |
Non-LZD | Case8 | 24–34 | 77 | II | − | − | INH-RIF-PZA-EMB-Lfx | Death | |
Case9 | 15–24 | 3 | II | − | − | INH-RIF-PZA-EMB | Survival | ||
Case10 | 25–34 | 21 | III | − | + | INH-PZA-Mfx-Pto-Am | Survival | ||
Case11 | 45–54 | 1 | I | − | + | INH-RIF-PAZ-EMB | Death | ||
Case12 | 45–54 | 3 | III | − | − | INH-PZA-EMB-Lfx-Am | death |